25
Participants
Start Date
December 10, 2024
Primary Completion Date
February 28, 2026
Study Completion Date
February 28, 2026
Efgartigimod PH20 SC
Subcutaneous injection of efgartigimod PH20 SC
RECRUITING
MedStar Washington Hospital Center, Washington D.C.
RECRUITING
Horizon Clinical Research: Gill Neuroscience, Cypress
RECRUITING
Velocity Clinical Research, Raleigh
RECRUITING
Neurology Associates PA, Maitland
RECRUITING
Visionary Investigators Network, Miami
RECRUITING
Vanderbilt University Medical Center, Nashville
RECRUITING
Erlanger Neuroscience Institute, Chattanooga
RECRUITING
SRI International - ClinEdge, Plymouth
RECRUITING
Northwestern Memorial Hospital, Chicago
RECRUITING
Velocity Clinical Research, Lafayette
RECRUITING
Cedar Health Research - Dallas, Dallas
RECRUITING
Northwest Houston Neurology - Cypress, Cypress
RECRUITING
National Neuromuscular Research Institute, Austin
Lead Sponsor
argenx
INDUSTRY